News

6 Sep 2024

Message on the passing of Dr Alwyn Mwinga from DNDi Executive Director Dr Luis Pizarro

Stories

2 Sep 2024

From Ituri to Geneva, in the search for new medicines for river blindness

Scientific articles

30 Aug 2024

The case for a global therapeutics development coalition: Building a therapeutics pipeline for pandemic and endemic diseases

PLOS Global Public Health

Scientific articles

15 Aug 2024

Paving the way for affordable and equitable liposomal amphotericin B access worldwide

The Lancet Global Health

Scientific articles

8 Aug 2024

The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis

Trends in Parasitology

Scientific articles

1 Aug 2024

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Lancet Infectious Diseases

Statements

31 Jul 2024

DNDi submission to Global Goal on Adaptation UAE-Belem Work programme on Indicators for UAE Framework for Global Climate Resilience

Statements

24 Jul 2024

DNDi response to Request for Information on draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning

Press releases

17 Jul 2024

Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease

Publications

17 Jul 2024

The Science Explained: Good news for people living with PKDL in Eastern Africa

Scientific articles

15 Jul 2024

Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome

Journal of Epidemiology and Global Health

Scientific articles

15 Jul 2024

Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements

Wellcome Open Research